VEGFA and ovarian carcinoma: In particular, we found PI3K-Akt initiators; such as the RTKs EGFR1 and VEGFA, and the integrins ITGB3 and ITGB6, to be potential drug targets in ovarian cancer patients with high CTCFL expression.